HIV-Human Peritonal Macrophage Interactions

HIV-人腹膜巨噬细胞相互作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): Macrophages, one of the major cell types in which HIV can both productively replicate and persist in a latent state, play a crucial role in HIV pathogenesis. In contrast to CD4+ T cells, macrophages are resistant to HIV-induced killing and have long lifespan. Indeed, macrophages appear to be an important reservoir and sustain high virus loads after depletion of CD4+ T cells in AIDS patients and in highly pathogenic SHIV- infected rhesus macaques. Importantly, macrophages are the major source of HIV during opportunistic infections, which occur more frequently during the advanced stages of AIDS. Because the long-lived HIV reservoirs constitute a major obstacle to HIV eradication, understanding the cellular and molecular mechanisms underlying HIV-macrophage interactions is vital for developing novel and efficacious therapeutic strategies against HIV and the AIDS epidemic. Susceptibility of primary macrophages to HIV depends on the anatomical location and activation state of the cells. Experimental investigation of the interactions between HIV-1 and macrophages has been impeded by the difficulty of isolating a large amount of human primary macrophages. We recently demonstrate that peritoneal macrophages (PMs) are highly abundant in ascitic fluid of patients with cirrhosis and are susceptible to HIV-1 infection. These cells are long-lived in vitro and can be cryopreserved. Freshly isolated PMs are susceptible to HIV R5, X4, X4R5 primary isolates by not but not to X4-T cell line adapted (TCLA) strains. Interestingly, after 7 days in culture, PMs acquired susceptibility to X4-TCLA strains and produced greater amounts of primary X4 and X4R5 HIV than freshly-isolated PMs. Concurrently, the level of CXCR4 mRNA and production of CC-chemokines increased significantly during 7 days in culture, suggesting that an increase in levels of HIV-coreceptors and CC-chemokines may contribute to the susceptibility to X4-TCLA and enhanced viral production of X4-ultizing isolates, respectively. HIV coreceptor switch from R5 to X4 has been associated with rapid CD4+ T cell loss and progression of AIDS when macrophages are the major source of HIV. Although the basis for HIV co-receptor switch is attributed to the complex interaction of the viral population with various cell populations of the immune system, the contribution by macrophages to HIV co-receptor switch is not known. Our long-term goal is to determine whether macrophages serve as an important reservoir and whether they play a role in HIV-coreceptor switch at the late stage of disease progression. Thus, further characterization of HIV-peritoneal macrophage interactions will offer an important insight into the role of macrophages in HIV pathogenesis. The goal of this proposal is to dissect the underlying mechanisms of dynamic HIV co-receptor usages in PMs and to amplify and characterize HIV envelopes from peritoneal macrophages from HIV-infected individuals. The outcome of this study will enhance our understanding of the role of macrophages in HIV pathogenesis and may facilitate discoveries of new ways for treatment. PUBLIC HEALTH RELEVANCE: The goal of this proposal is to dissect the underlying mechanisms of dynamic HIV co-receptor usages in PMs and to characterize HIV Env in PMs from HIV-infected patients.
描述(由申请人提供):巨噬细胞是 HIV 能够高效复制并持续处于潜伏状态的主要细胞类型之一,在 HIV 发病机制中发挥着至关重要的作用。与 CD4+ T 细胞相比,巨噬细胞能够抵抗 HIV 诱导的杀伤,并且寿命较长。事实上,巨噬细胞似乎是一个重要的储存库,在艾滋病患者和感染高致病性 SHIV 的恒河猴体内 CD4+ T 细胞耗尽后,巨噬细胞仍能维持高病毒载量。重要的是,巨噬细胞是机会性感染期间艾滋病毒的主要来源,这种情况在艾滋病晚期更常见。由于长寿命的艾滋病毒储存库构成了根除艾滋病毒的主要障碍,因此了解艾滋病毒-巨噬细胞相互作用的细胞和分子机制对于开发针对艾滋病毒和艾滋病流行的新颖有效的治疗策略至关重要。 原代巨噬细胞对 HIV 的易感性取决于细胞的解剖位置和激活状态。由于难以分离大量人类原代巨噬细胞,HIV-1 和巨噬细胞之间相互作用的实验研究受到阻碍。我们最近证明,肝硬化患者腹水中的腹膜巨噬细胞(PM)非常丰富,并且容易受到 HIV-1 感染。这些细胞在体外寿命很长,并且可以冷冻保存。新鲜分离的 PM 对 HIV R5、X4、X4R5 原代分离株敏感,但对 X4-T 细胞系适应 (TCLA) 菌株不敏感。有趣的是,培养 7 天后,PM 获得了对 X4-TCLA 菌株的敏感性,并比新鲜分离的 PM 产生更多量的原代 X4 和 X4R5 HIV。同时,CXCR4 mRNA 的水平和 CC 趋化因子的产量在培养 7 天期间显着增加,表明 HIV 辅助受体和 CC 趋化因子水平的增加可能分别有助于 X4-TCLA 的易感性和 X4-ultizing 分离株的病毒产量的增加。 当巨噬细胞是 HIV 的主要来源时,HIV 辅助受体从 R5 到 X4 的转换与 CD4+ T 细胞的快速损失和 AIDS 的进展相关。尽管HIV共受体转换的基础归因于病毒群体与免疫系统的各种细胞群的复杂相互作用,但巨噬细胞对HIV共受体转换的贡献尚不清楚。我们的长期目标是确定巨噬细胞是否作为重要的储存库,以及它们是否在疾病进展后期的 HIV 辅助受体转换中发挥作用。因此,HIV-腹膜巨噬细胞相互作用的进一步表征将为巨噬细胞在 HIV 发病机制中的作用提供重要的见解。 该提案的目标是剖析 PM 中动态 HIV 共受体使用的基本机制,并放大和表征 HIV 感染者腹膜巨噬细胞的 HIV 包膜。这项研究的结果将增强我们对巨噬细胞在艾滋病毒发病机制中的作用的理解,并可能有助于发现新的治疗方法。 公共健康相关性:本提案的目标是剖析 PM 中动态 HIV 共受体使用的基本机制,并描述 HIV 感染者 PM 中 HIV 包膜的特征。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Theresa L Chang其他文献

Theresa L Chang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Theresa L Chang', 18)}}的其他基金

Sex difference in intestinal immune dysfunction, SHIV infection and reservoir
肠道免疫功能障碍、SHIV感染和储存者的性别差异
  • 批准号:
    10654740
  • 财政年份:
    2021
  • 资助金额:
    $ 19.77万
  • 项目类别:
Impact of gender affirming hormone therapy on immune modulation and HIV infection in transgender young adults
性别肯定激素治疗对跨性别年轻人免疫调节和艾滋病毒感染的影响
  • 批准号:
    10364706
  • 财政年份:
    2021
  • 资助金额:
    $ 19.77万
  • 项目类别:
Sex difference in intestinal immune dysfunction, SHIV infection and reservoir
肠道免疫功能障碍、SHIV感染和储存者的性别差异
  • 批准号:
    10462764
  • 财政年份:
    2021
  • 资助金额:
    $ 19.77万
  • 项目类别:
Sex difference in intestinal immune dysfunction, SHIV infection and reservoir
肠道免疫功能障碍、SHIV感染和储存者的性别差异
  • 批准号:
    10327456
  • 财政年份:
    2021
  • 资助金额:
    $ 19.77万
  • 项目类别:
Impact of gender affirming hormone therapy on immune modulation and HIV infection in transgender young adults
性别肯定激素治疗对跨性别年轻人免疫调节和艾滋病毒感染的影响
  • 批准号:
    10257722
  • 财政年份:
    2021
  • 资助金额:
    $ 19.77万
  • 项目类别:
Role of IFNe in immune modulation and HIV infection
IFNe在免疫调节和HIV感染中的作用
  • 批准号:
    10356898
  • 财政年份:
    2018
  • 资助金额:
    $ 19.77万
  • 项目类别:
Modulation of innate immunity,microbiome and HIV transmission by Depo-Provera
Depo-Provera 对先天免疫、微生物组和 HIV 传播的调节
  • 批准号:
    9045100
  • 财政年份:
    2013
  • 资助金额:
    $ 19.77万
  • 项目类别:
Modulation of innate immunity,microbiome and HIV transmission by Depo-Provera
Depo-Provera 对先天免疫、微生物组和 HIV 传播的调节
  • 批准号:
    8716673
  • 财政年份:
    2013
  • 资助金额:
    $ 19.77万
  • 项目类别:
Modulation of innate immunity,microbiome and HIV transmission by Depo-Provera
Depo-Provera 对先天免疫、微生物组和 HIV 传播的调节
  • 批准号:
    8885647
  • 财政年份:
    2013
  • 资助金额:
    $ 19.77万
  • 项目类别:
Modulation of innate immunity,microbiome and HIV transmission by Depo-Provera
Depo-Provera 对先天免疫、微生物组和 HIV 传播的调节
  • 批准号:
    8593906
  • 财政年份:
    2013
  • 资助金额:
    $ 19.77万
  • 项目类别:

相似海外基金

Open Access Block Award 2024 - NHS Blood and Transplant NHSBT School
2024 年开放获取块奖 - NHS 血液和移植 NHSBT 学校
  • 批准号:
    EP/Z532551/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.77万
  • 项目类别:
    Research Grant
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
  • 批准号:
    MR/X032809/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.77万
  • 项目类别:
    Fellowship
A cluster randomized controlled trial to evaluate pharmacy-based health promotion program to improve blood pressure control in Bangladesh, India and Pakistan
一项整群随机对照试验,旨在评估孟加拉国、印度和巴基斯坦基于药房的健康促进计划,以改善血压控制
  • 批准号:
    23K24566
  • 财政年份:
    2024
  • 资助金额:
    $ 19.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
経胸壁心臓超音波のBlood Speckle Imagingを用いた大動脈弓部病変評価の研究
经胸心脏超声血斑成像评价主动脉弓病变的研究
  • 批准号:
    24K10591
  • 财政年份:
    2024
  • 资助金额:
    $ 19.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
STTR Phase I: A Completely Non-Toxic Blood Bag That Keeps Blood Healthier, Longer
STTR 第一阶段:完全无毒的血袋,使血液保持更健康、更长久
  • 批准号:
    2335363
  • 财政年份:
    2024
  • 资助金额:
    $ 19.77万
  • 项目类别:
    Standard Grant
How blood vessel stiffness regulates their growth and maintenance
血管硬度如何调节其生长和维持
  • 批准号:
    DE240101055
  • 财政年份:
    2024
  • 资助金额:
    $ 19.77万
  • 项目类别:
    Discovery Early Career Researcher Award
Engaging the over 50s to ensure the sustainability of our blood supply
让 50 多岁的人参与进来,确保我们血液供应的可持续性
  • 批准号:
    LP220200819
  • 财政年份:
    2024
  • 资助金额:
    $ 19.77万
  • 项目类别:
    Linkage Projects
A methodology to connect functionalized gonadal constructs to a chick embryo through mechanically induced blood vessels from an egg
一种通过鸡蛋机械诱导血管将功能化性腺结构连接到鸡胚胎的方法
  • 批准号:
    24K15741
  • 财政年份:
    2024
  • 资助金额:
    $ 19.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Applying a Program Science approach for strengthening partnerships and advancing embedded research to optimize public health programming for HIV and sexually transmitted and blood-borne infections among criminalized populations in the Global South
应用计划科学方法来加强伙伴关系并推进嵌入式研究,以优化南半球犯罪人群中针对艾滋病毒、性传播和血源性感染的公共卫生规划
  • 批准号:
    502554
  • 财政年份:
    2024
  • 资助金额:
    $ 19.77万
  • 项目类别:
Designing and fabricating artificial blood cells for global shortages
设计和制造人造血细胞应对全球短缺
  • 批准号:
    DE240100236
  • 财政年份:
    2024
  • 资助金额:
    $ 19.77万
  • 项目类别:
    Discovery Early Career Researcher Award
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了